Tele2 AB (publ) (TEL2-B)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 157.45 |
|---|---|
| 52-week range | 143.05 – 198.30 |
| Return, 1 month / 3 months | −3.0% / −1.6% |
| Return, 1 year / 3 years | +9.9% / +137.9% |
| Trend | Below its 200-day average |
| RSI (14) | 48 |
| Volatility (1 year) | 20.9% |
| Worst drawdown (1 year) | -18.6% |
| Average daily value traded | 349.78M SEK |
| Dividend yield | 6.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Tele2 AB is a telecommunications operator based in Sweden. It provides mobile telephony, fixed broadband, television and data services to households and business customers. The company serves consumer and enterprise markets in Sweden and the Baltic region, offering mobile plans, internet access and related communications services. Its business centres on connecting customers through its own networks and through wholesale arrangements with other operators.
Tele2 AB (publ) trades under the code TEL2-B on the Nasdaq Stockholm in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Tele2 AB (publ) (TEL2-B) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 157.45 on 27 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 158 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.9% and over the last three months it fell 1.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -5.8% | ||
| From 52-week high | -20.3% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.6% | ||
| 6-month return | -9.7% | ||
| 12-month return, skipping the last month | 13.3% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.6% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 349.78M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 74 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.7% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.2% |
|---|---|
| 1 month | −3.0% |
| 3 months | −1.6% |
| 6 months | −9.7% |
| 1 year | +9.9% |
| 3 years | +137.9% |
| 5 years | +71.7% |
Signals
| 50-day / 200-day average | 160.82 / 167.09 |
|---|---|
| Golden / death cross (60 days) | Death, 48 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.27 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Oct 2026 | SEK 5.2500 |
| 19 May 2026 | SEK 5.2500 |
| 9 Oct 2025 | SEK 3.1500 |
| 14 May 2025 | SEK 3.2000 |
| 14 Oct 2024 | SEK 3.4500 |
| 16 May 2024 | SEK 3.4500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.